期刊文献+

奥曲肽对前列腺癌细胞株PC-3的抑制作用及对VEGF表达的影响 被引量:3

Inhibitory Effects of Octreotide on Prostate Cancer PC-3 Cell Line and Expression of VEGF
原文传递
导出
摘要 目的:探讨奥曲肽(生长抑素类似物)对雄激素非依赖性前列腺癌细胞株PC-3的抑制作用及对其血管内皮生长因子(VEGF)表达的影响。方法:分别用浓度为0.1、0.3、1.0、3.0 mg/L奥曲肽对体外培养的人前列腺癌PC 3细胞进行处理,24 h、48 h、72 h后采用MTT法检测细胞生长活性,行Hoechst33258染色,用荧光显微镜观察细胞凋亡的形态学改变;用RT PCR法测定细胞半胱氨酸天门冬氨酸蛋白酶3(Caspase-3)及VEGF的表达。结果:奥曲肽能以剂量与时间依赖性的方式抑制PC-3细胞的生长,促进其凋亡;0.1、0.3、1.0、3.0 mg/L奥曲肽作用PC-3细胞24 h后的存活率分别为(0.971±0.01 6)%、(0.853±0.01 5)%、(0.717±0.031)%、(0.743±0.029)%,作用48 h后的存活率分别为(0.918±0.015)%、(0.835±0.015)%、(0.682±0.018)%、(0.727±0.014)%,作用72 h后的存活率分别为(0.922±0.017)%、(0.841±0.01 3)%、(0.717±0.017)%、(0.739±0.003)%,差别有统计学意义(P<0.01);Caspase-3表达较对照组明显升高;而VEGF则明显降低。结论:奥曲肽能显著抑制PC 3细胞的体外生长,促进其凋亡;VEGF可能是其中的一条途径。 Objective:To investigate the inhibitory effects of octreotide (somatostatin analogs) on androgen independent prostate cancer PC-3 cell line and the expression of vascular endothelial growth factor(VEGF). Methods:After PC-3 cells were induced by 0.1,0.3,1.0,3.0 mg/L octreotide respectively, the cell acitvity was assayed by MTT at 24,48 and 72 hours, the morphology of apoptosis was observed by Hoechst 33258 staining under fluo rescence microscope. The level of caspase-3 and VEGF were detected by reverse transeription-polymerase chain reaction (RT PCR). Results:Octreotide could suppress the growth and promote the apoptosis of PC-3 cells in dosedependent and time-dependent manners, and the morphology of apoptosis could be examined in the study. When cells were treated with different concentrations of oetreotide (0. 1, 0.3, 1.0 and 3.0 rag/L), the cell surviving rate was (0. 971 ± 0.016)%,(0.853 ± 0.015)%, (0. 717 ±0.031)%,(0.743 ±0.029)% respectively at 24hours,(0.918 ± 0.015)%,(0.835 ± 0.015)%,(0.682± 0.018)%,(0.727 ± 0.014)% respectively at 48 hours and (0.922± 0. 017)%,(0. 841 ± 0.013)%,(0.717± 0.017)%,(0.739 2± 0.003)% respectively at 72 hours,the difference was obviously significant among them. The expression of Caspase-3 was upregulated while VEGF downregulated. Conclusions:Octreotide can suppress the growth and promote the apoptosis of PC 3 cells, and VEGF may involve in it.
出处 《临床泌尿外科杂志》 北大核心 2010年第6期469-473,共5页 Journal of Clinical Urology
关键词 前列腺癌 奥曲肽 细胞凋亡 血管内皮生长因子 prostatic carcinoma octreotide cell apoptosis vascular endothelial growth factor
  • 相关文献

参考文献8

  • 1Wingo P A,Cardinez C J,Landis S H,et al.Long-term trends in cancer mortality in the United States,1930-1998[J].Cancer,2003,97(12 Suppl):3133-3275.
  • 2Senger D R,Galli S J,Dvorak A M,et al.Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid[J].Science,1983,219(4587):983-985.
  • 3Carmeliet Jain R K.Angiogenesis in cancer and other diseases[J].Nature,2000,407 (6801):249-257.
  • 4Tsao M S,Liu N,Nicklee T,et al.Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activition in non-small cell lung carcinoma[J].Clin Cancer Res,1997,3(10):1807-1814.
  • 5Jiuhua LIU,Wei ZHANG.Expression of COX-2 and VEGF in human prostate cancer and the relationships between them and tumor angiogenesis[J].ACTA Universitatis Medicinalis Nanjing(Natural Science),2006,26(10):909-912.
  • 6陈筠,齐自宁,董秀山,陈孝平.生长抑素类似物抑制胆管癌细胞增殖的研究[J].中国药物与临床,2007,7(1):16-19. 被引量:4
  • 7Kerr J F R,Wyllie A H,Currie A R.Apoptosis:a basic biologicaI phenomenon with wide ranging implications in tissue kinetics[J].Br J Cancer,1972,24:239.
  • 8Cong-mei W U.Effect of small heterocyclic compound S1 on inducing PC-3 cell line apoptosis[J].Journal of Jilin University(Medicine Edition),2008,34 (3):361 -363.

二级参考文献1

共引文献3

同被引文献31

  • 1郑文斌,王春晖,强鸥,唐承薇.塞来昔布联合奥曲肽对人胃癌多药耐药细胞生长的影响[J].癌症,2004,23(12):1628-1632. 被引量:8
  • 2张保国,姚乐申.奥曲肽对人类前列腺癌PC-3细胞凋亡及其对cyclinE蛋白表达的影响[J].南京医科大学学报(自然科学版),2005,25(12):928-930. 被引量:1
  • 3侯振江,李永乾.蛋白质组学及其在前列腺癌研究中的应用[J].中华男科学杂志,2006,12(4):358-361. 被引量:3
  • 4Buschemeyer WC 3rd, Freedland SJ. Obesity and prostate cancer:epidemiology and clinical implications [ J ]. Eur Urol, 2007,52 ( 2 ) : 331 - 343.
  • 5Attar RM, Takimoto CH, Gottardis MM. Castration-resistant prostate cancer:locking up the molecular escape routes [ J ]. Clin Cancer Res, 2009,15 ( 10 ) :3251-3255.
  • 6Mentlein R, Eichler O, Forstreuter F, et al. Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells [ J ]. lnt J Cancer,2001,92 (4) :545-550.
  • 7Gill ML, Aliq M,Sattar S,et al. Treatment outcomes with long acting octreotide in inoperable hepatocellular carcinoma: a local experience and review of literature[ J]. J Pak Med Assoc,2005,55 (4) :135-138.
  • 8Oberg KE, Reubi JC, Kwekkeboom DJ, et al. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy [ J]. Gastroenterology,2010,139 ( 3 ) :742-753.
  • 9Tang C, Liu C,Zhou X,et al. Enhanced inhibitive effects of combination of rofecoxib and octreotide on the growth of human gastric cancer [ J ]. Int J Cancer, 2004,112 ( 3 ) :470 -474.
  • 10Friedlander TW, Weinberg VK, Small EJ, et al. Effect of the somatostatin analog octreotide acetale on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castrationresistant prostate cancer : Results of a phase II study [ J ]. Urol Oncol, 2010,Epub ahead of print.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部